BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7896428)

  • 1. Blood compatibility of two different types of membrane oxygenator during cardiopulmonary bypass in infants.
    Gu YJ; Boonstra PW; Akkerman C; Mungroop H; Tigchelaar I; Van Oeveren W
    Int J Artif Organs; 1994 Oct; 17(10):543-8. PubMed ID: 7896428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: a comparison between hollow fiber and flat sheet membrane oxygenators.
    Gu YJ; Boonstra PW; Graaff R; Rijnsburger AA; Mungroop H; van Oeveren W
    Artif Organs; 2000 Jan; 24(1):43-8. PubMed ID: 10677156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation.
    van Oeveren W; Kazatchkine MD; Descamps-Latscha B; Maillet F; Fischer E; Carpentier A; Wildevuur CR
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):888-99. PubMed ID: 3158783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood--artificial surface interactions during cardiopulmonary bypass. A comparative study of four oxygenators.
    Benedetti M; De Caterina R; Bionda A; Gardinali M; Cicardi M; Maffei S; Gazzetti P; Pistolesi P; Vernazza F; Michelassi C
    Int J Artif Organs; 1990 Aug; 13(8):488-97. PubMed ID: 2146229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of a silicone-coated polypropylene hollow fiber oxygenator in an in vitro model.
    Watanabe H; Hayashi J; Ohzeki H; Moro H; Sugawara M; Eguchi S
    Ann Thorac Surg; 1999 May; 67(5):1315-9. PubMed ID: 10355404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility of three different membrane oxygenators: effects on complement, neutrophil and monocyte activation.
    de Vroege R; Rutten PM; Kalkman C; Out TA; Jansen PG; Eijsman L; de Mol BJ; Wildevuur CR
    Perfusion; 1997 Nov; 12(6):369-75. PubMed ID: 9413849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation during cardiopulmonary bypass. Comparison of bubble and membrane oxygenators.
    Cavarocchi NC; Pluth JR; Schaff HV; Orszulak TA; Homburger HA; Solis E; Kaye MP; Clancy MS; Kolff J; Deeb GM
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):252-8. PubMed ID: 3511328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet activation and degradation in an experimental extracorporeal system. A comparison between a silicone membrane and a hollow-fibre oxygenator.
    Mellgren K; Skogby M; Järnås A; Friberg LG; Wadenvik H; Mellgren G
    Perfusion; 1996 Sep; 11(5):383-8. PubMed ID: 8888060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hollow fibre membrane oxygenators during cardiopulmonary bypass in children: Dideco Masterflo versus Terumo Capiox II.
    Leijala M; Peltola K; Aronen M; Meri S; Louhimo I
    Perfusion; 1990; 5(1):33-43. PubMed ID: 10149485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuit.
    Bochenek A; Religa Z; Kustosz R; Wnuk-Wojnar AM; Wnuk R; Wojnar J; Woś S; Wites M; Zembala M; Spyt T
    Nephrol Dial Transplant; 1991; 6 Suppl 3():75-80. PubMed ID: 1775272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet function during cardiac operation: comparison of membrane and bubble oxygenators.
    Edmunds LH; Ellison N; Colman RW; Niewiarowski S; Rao AK; Addonizio VP; Stephenson LW; Edie RN
    J Thorac Cardiovasc Surg; 1982 Jun; 83(6):805-12. PubMed ID: 7087507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
    Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
    Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators.
    Peterson KA; Dewanjee MK; Kaye MP
    J Thorac Cardiovasc Surg; 1982 Jul; 84(1):39-43. PubMed ID: 7087539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematological effects of a new hollow fiber membrane oxygenator: a clinical study.
    Ennema JJ; Karliczek GF; Gerding A; Tigchelaar I; Dijck L; Harder MP; van der Heide JN; Wildevuur CR
    Thorac Cardiovasc Surg; 1984 Apr; 32(2):96-9. PubMed ID: 6204417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bubble and membrane oxygenators in short and long perfusions.
    Clark RE; Beauchamp RA; Magrath RA; Brooks JD; Ferguson TB; Weldon CS
    J Thorac Cardiovasc Surg; 1979 Nov; 78(5):655-66. PubMed ID: 491720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three commercially available hollow fiber oxygenators: gas transfer performance and biocompatibility.
    de Vroege R; Wagemakers M; te Velthuis H; Bulder E; Paulus R; Huybregts R; Wildevuur W; Eijsman L; van Oeveren W; Wildevuur C
    ASAIO J; 2001; 47(1):37-44. PubMed ID: 11199313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system].
    Bochenek A; Religa Z; Kokot F; Knapik P; Wnuk R; Komarski K; Wojnar J; Pietrzycki A; Skiba J
    Kardiol Pol; 1992; 36(2):67-72. PubMed ID: 1583828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.